Author

S. Quataert

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:scRNA-seq· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Embong· 1 shared A. R. Fullen· 1 shared B. D. Korman· 1 shared C. T. Ritchlin· 1 shared C.-L. Wu· 1 shared E. M. Schwarz· 1 shared E. Pritchett· 1 shared G. Muthukrishnan· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Embong

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Multi-omics Analysis Identifies IgG2b Class-Switching with ALCAM-CD6 Co-Stimulation in Lymph Nodes During Advanced Inflammatory-Erosive Arthritis

H. M. Kenney, J. Rangel-Moreno, Y. Peng, K. L. Chen, J. Bruno, A. Embong, E. Pritchett, J. I. Fox, S. Quataert, G. Muthukrishnan, R. W. Wood, B. D. Korman, J. H. Anolik, L. Xing, C. T. Ritchlin, , C.-L. Wu

The paper identifies ALCAM-CD6 co-stimulation as a pathway promoting IgG2b class-switching in lymph nodes during advanced inflammatory arthritis using spatial and single-cell transcriptomics.

bioRxiv · Oct 27, 2022 · PreprintImmunology

Bordetella Colonization Factor A (BcfA) elicits protective immunity against Bordetella bronchiseptica in the absence of an additional adjuvant

K. S. Yount, J. Jennings-Gee, K. Caution, A. R. Fullen, K. N. Corps, S. Quataert, R. Deora, P. Dubey

This study shows that BcfA can act as both an antigen and adjuvant, providing protection against B. bronchiseptica without additional adjuvants.

bioRxiv · Jul 4, 2019Immunology